← FDA Drug Approvals (Drugs@FDA)

OCREVUS

BLA · Biologics License Application · Sponsor: GENENTECH INC · Approved 2017-03-28

Drug application

FDA Application #
BLA761053
Application type
Biologics License Application
Brand name
OCREVUS
Generic name
OCRELIZUMAB
Active ingredients
OCRELIZUMAB
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Prescription
Sponsor
GENENTECH INC
Manufacturer
Genentech, Inc.
First approval
2017-03-28

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown